Zymeworks
ZYME
15 hedge funds and large institutions have $13.7M invested in Zymeworks in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
25% more funds holding
Funds holding: 12 → 15 (+3)
0.02% less ownership
Funds ownership: 7.31% → 7.29% (-0.02%)
7% less capital invested
Capital invested by funds: $14.8M → $13.7M (-$1.07M)
Top Buyers
| 1 |
PA
Perceptive Advisors
New York
|
+$384K |
| 2 |
VF
Virtu Financial
New York
|
+$96.8K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$95.4K |
| 4 |
Parallax Volatility Advisers
San Francisco,
California
|
+$14K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$12.9K |
Top Sellers
ZYME Hedge Fund Activity: Q4 2017 in Review
15 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q4 2017, worth a combined $13.7M — down 7.3% from $14.8M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new ZYME positions and 3 closed out — a net gain of 3 holders — while 4 added to existing stakes and 2 trimmed.
The largest buyer was Perceptive Advisors, adding an estimated $384K. The largest seller was Royal Bank of Canada, cutting an estimated $461K.
- 15 institutional investors held Zymeworks (ZYME) as of Q4 2017, up from 12 in Q3 2017.
- Funds reported $13.7M of Zymeworks stock for Q4 2017, down 7.3% quarter-over-quarter.
- 6 funds opened new Zymeworks positions in Q4 2017 and 3 closed out, a net change of +3 holders.
- The largest Zymeworks buyer in Q4 2017 was Perceptive Advisors, an estimated $384K added.
- The largest Zymeworks seller in Q4 2017 was Royal Bank of Canada, an estimated $461K sold.
Based on aggregated 13F filings for Q4 2017.